Thermo Fisher Scientific Inc [NYSE: TMO] price plunged by -1.15 percent to reach at -$4.98.
The one-year TMO stock forecast points to a potential upside of 26.98. The average equity rating for TMO stock is currently 1.53, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Thermo Fisher Scientific Inc [TMO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TMO shares is $584.31 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TMO stock is a recommendation set at 1.53. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Bernstein have made an estimate for Thermo Fisher Scientific Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, Scotiabank raised their target price to Sector Perform. The new note on the price target was released on December 23, 2024, representing the official price target for Thermo Fisher Scientific Inc stock.
The Average True Range (ATR) for Thermo Fisher Scientific Inc is set at 18.54, with the Price to Sales ratio for TMO stock in the period of the last 12 months amounting to 3.75. The Price to Book ratio for the last quarter was 3.28, with the Price to Cash per share for the same quarter was set at 15.75. Price to Free Cash Flow for TMO in the course of the last twelve months was 23.95 with Quick ratio for the last quarter at 1.38.
TMO Stock Performance Analysis:
Thermo Fisher Scientific Inc [TMO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.32. With this latest performance, TMO shares dropped by -17.05% in over the last four-week period, additionally sinking by -28.34% over the last 6 months – not to mention a drop of -22.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TMO stock in for the last two-week period is set at 35.86, with the RSI for the last a single of trading hit 36.92, and the three-weeks RSI is set at 35.79 for Thermo Fisher Scientific Inc [TMO]. The present Moving Average for the last 50 days of trading for this stock 495.49, while it was recorded at 428.48 for the last single week of trading, and 552.03 for the last 200 days.
Insight into Thermo Fisher Scientific Inc Fundamentals:
Thermo Fisher Scientific Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.38 and a Current Ratio set at 1.77.
TMO Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TMO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Thermo Fisher Scientific Inc go to 8.20%.
Thermo Fisher Scientific Inc [TMO] Institutonal Ownership Details
There are presently around $92.62%, or 92.79%% of TMO stock, in the hands of institutional investors. The top three institutional holders of TMO stocks are: VANGUARD GROUP INC with ownership of 32.73 million shares, which is approximately 8.5678%. BLACKROCK INC., holding 29.53 million shares of the stock with an approximate value of $$16.33 billion in TMO stocks shares; and BLACKROCK INC., currently with $$8.96 billion in TMO stock with ownership which is approximately 4.2393%.
